Covidien Unit Targets Watson Over Generic Exalgo
A Covidien PLC subsidiary has sued specialty pharmaceutical company Watson Pharmaceuticals Inc. in an effort to stop it from marketing a generic version of painkiller Exalgo....To view the full article, register now.
Already a subscriber? Click here to view full article